Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …

German Chancellor Dr Angela Merkel met with Sanofi bosses in Frankfurt to discuss antibiotics and open a new manufacturing facility. …

UK’s Huntingdon Life Sciences and Harlan Laboratories has appointed Dr Joseph Bedford to serve as corporate vice president of global …

Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …

Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …

Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …

The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …

French software solutions provider for clinical trials Kayentis has formed a strategic committee comprising four industry veterans. Accepting director Guillaume …
A Chinese health official has been arrested on accusations of bribery as the country continues to crack down on corruption …

Novartis’ first ASCO conference since buying GlaxoSmithKline’s oncology business will be showcasing drugs from the acquisition. The two firms swapped …

Amgen is pinning its hopes on investigational viral treatment T-VEC following promising results from a ‘landmark’ skin cancer study. People …

Eisai’s UK subsidiary has received a positive opinion from the European Medicines Agency for using Fycompa for the adjunctive treatment …

Sanofi has said Suresh Kumar is to join the French pharma giant on its executive committee and become executive vice …
Ergomed plc, the parent company of PrimeVigilance, has acquired Sound Opinion, one of the UK’s leading Medical Information (MI) service …

Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …

A ‘senior male employee’ of Otsuka Pharmaceuticals “potentially brought the industry into disrepute” by plying a female healthcare professional with …

Amgen has ended its agreement with AstraZeneca to develop a new biologic for psoriasis, because of the likelihood of ‘restrictive …

Canadian biotech Medicago is building a $245 million new production complex in Quebec to make more vaccines and therapeutics based …

Austrian-based clinical stage biopharma firm Nabriva Therapeutics has appointed Dr Elyse Seltzer as its chief medical officer. Seltzer assumes the role …

In May the UK went to the polls and elected a Conservative government to replace the coalition that had been …